BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int J Mol Sci 2014;15:9184-208. [PMID: 24865485 DOI: 10.3390/ijms15069184] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Hagan H, Jordan AE, Neurer J, Cleland CM. Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men. AIDS 2015;29:2335-45. [PMID: 26258525 DOI: 10.1097/QAD.0000000000000834] [Cited by in Crossref: 147] [Cited by in F6Publishing: 65] [Article Influence: 24.5] [Reference Citation Analysis]
2 Shrivastava S, Kottilil S, Sherman KE, Masur H, Tang L. CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients. Viruses 2021;13:2074. [PMID: 34696504 DOI: 10.3390/v13102074] [Reference Citation Analysis]
3 Blanco JR, Negredo E, Bernal E, Blanco J. Impact of HIV infection on aging and immune status. Expert Rev Anti Infect Ther 2021;19:719-31. [PMID: 33167724 DOI: 10.1080/14787210.2021.1848546] [Reference Citation Analysis]
4 Ranin J, Salemovic D, Brmbolic B, Marinkovic J, Boricic I, Pesic PI, Zerjav S, Stanojevic M, Jevtovic D. Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study. Curr HIV Res 2018;16:222-30. [PMID: 30014804 DOI: 10.2174/1570162X16666180717115614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Gobran ST, Ancuta P, Shoukry NH. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection. Front Immunol 2021;12:726419. [PMID: 34456931 DOI: 10.3389/fimmu.2021.726419] [Reference Citation Analysis]
6 Famakinde DO, Adenusi AA. Involvement of Hookworm Co-Infection in the Pathogenesis and Progression of Podoconiosis: Possible Immunological Mechanism. Trop Med Infect Dis 2018;3:E37. [PMID: 30274434 DOI: 10.3390/tropicalmed3020037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Devi P, Khan A, Chattopadhyay P, Mehta P, Sahni S, Sharma S, Pandey R. Co-infections as Modulators of Disease Outcome: Minor Players or Major Players? Front Microbiol 2021;12:664386. [PMID: 34295314 DOI: 10.3389/fmicb.2021.664386] [Reference Citation Analysis]
8 Sims OT, Womack BG. Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings. Soc Work Public Health 2015;30:325-35. [PMID: 25811121 DOI: 10.1080/19371918.2014.1000506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Kaspar MB, Sterling RK. Mechanisms of liver disease in patients infected with HIV. BMJ Open Gastroenterol. 2017;4:e000166. [PMID: 29119002 DOI: 10.1136/bmjgast-2017-000166] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
10 Zheng XY, Zhao X, Yang YF, Jiang HJ, Li W, Sun Y, Pu XP. Antioxidant, antiapoptotic and amino acid balance regulating activities of 1,7-dihydroxy-3,4,8-trimethoxyxanthone against dimethylnitrosamine-induced liver fibrosis. PLoS One 2017;12:e0189344. [PMID: 29232404 DOI: 10.1371/journal.pone.0189344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Quiros-Roldan E, Castelli F, Lanza P, Pezzoli C, Vezzoli M, Biasiotto G, Zanella I; Inflammation in HIV Study Group. The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia. J Transl Med 2017;15:256. [PMID: 29258550 DOI: 10.1186/s12967-017-1358-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Farinatti P, Paes L, Harris EA, Lopes GO, Borges JP. A Simple Model to Identify Risk of Sarcopenia and Physical Disability in HIV-Infected Patients. J Strength Cond Res 2017;31:2542-51. [PMID: 28658070 DOI: 10.1519/JSC.0000000000002070] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Theron AJ, Anderson R, Rossouw TM, Steel HC. The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders. Front Immunol 2017;8:1461. [PMID: 29163528 DOI: 10.3389/fimmu.2017.01461] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
14 Salemovic D, Pesic-Pavlovic I, Jevtovic D, Bojovic K, Ranin J, Brmbolic B, Stanojevic M. Intravenous drug use - an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients. Arch Med Sci. 2017;13:652-658. [PMID: 28507583 DOI: 10.5114/aoms.2017.66022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
15 Mednikov RV, Rabinovich VI, Kizlo SN, Belyakov NA, Sokolov AA. Double Filtration Plasmapheresis in Treatment of Patients With Co-Infection of Hepatitis C and Human Immunodeficiency Virus. Ther Apher Dial 2016;20:413-9. [PMID: 27059644 DOI: 10.1111/1744-9987.12396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Vita S, Zuccalà P, Savinelli S, Mascia C, Rossi R, Schiavone F, Marocco R, Tieghi T, Iannetta M, Nijhawan P, Zingaropoli MA, d'Ettore G, Vullo V, Mastroianni CM, Lichtner M. Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection. J Immunol Res 2020;2020:2781350. [PMID: 32258171 DOI: 10.1155/2020/2781350] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Dobseu R, Nanfack A, Kowo M, Ambada G, Kamgaing R, Chenwi C, Fainguem N, Ka'e A, Ngangoum E, Sosso S, Tchiegang C, Ndjolo A. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings. BMC Infect Dis 2020;20:758. [PMID: 33059627 DOI: 10.1186/s12879-020-05477-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Griesbeck M, Valantin MA, Lacombe K, Samri-Hassimi A, Bottero J, Blanc C, Sbihi Z, Zoorob R, Katlama C, Guiguet M, Altfeld M, Autran B; HepACT-VIH study group. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals. AIDS 2017;31:1223-34. [PMID: 28492391 DOI: 10.1097/QAD.0000000000001455] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 MacBrayne CE, Marks KM, Fierer DS, Naggie S, Chung RT, Hughes MD, Kim AY, Peters MG, Brainard DM, Seifert SM, Castillo-Mancilla JR, Bushman LR, Anderson PL, Kiser JJ. Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother 2018;73:2112-9. [PMID: 29746648 DOI: 10.1093/jac/dky146] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
20 Owusu DO, Phillips R, Owusu M, Sarfo FS, Frempong M. Increased levels of circulating IL-10 in persons recovered from hepatitis C virus (HCV) infection compared with persons with active HCV infection. BMC Res Notes 2020;13:472. [PMID: 33028385 DOI: 10.1186/s13104-020-05313-w] [Reference Citation Analysis]
21 Hu J, Han H, Lau MY, Lee H, MacVeigh-Aloni M, Ji C. Effects of combined alcohol and anti-HIV drugs on cellular stress responses in primary hepatocytes and hepatic stellate and kupffer cells. Alcohol Clin Exp Res 2015;39:11-20. [PMID: 25623401 DOI: 10.1111/acer.12608] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
22 Shmagel NG, Shmagel KV, Saidakova EV, Korolevskaya LB, Chereshnev VA. Discordant response of CD4(+) T cells to antiretroviral therapy in HIV-infected patients coinfected with hepatitis C virus is accompanied by increased liver damage. Dokl Biochem Biophys 2015;465:358-60. [PMID: 26728724 DOI: 10.1134/S1607672915060034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Bi J, Ge S. Potential roles of BMP9 in liver fibrosis. Int J Mol Sci 2014;15:20656-67. [PMID: 25393508 DOI: 10.3390/ijms151120656] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
24 Shi L, Qin E, Zhou J, Zhao J, Nie W, Jiang T, Chen W, Wu D, Huang L, Liu L, Lv L, Zhao M, Zhang Z, Wang F. HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells. PLoS One 2016;11:e0158386. [PMID: 27362846 DOI: 10.1371/journal.pone.0158386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
25 Nyström J, Stenkvist J, Häggblom A, Weiland O, Nowak P. Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients. PLoS One 2015;10:e0118643. [PMID: 25785448 DOI: 10.1371/journal.pone.0118643] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
26 Liberto MC, Zicca E, Pavia G, Quirino A, Marascio N, Torti C, Focà A. Virological Mechanisms in the Coinfection between HIV and HCV. Mediators Inflamm 2015;2015:320532. [PMID: 26494946 DOI: 10.1155/2015/320532] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
27 Verstrepen BE, Nieuwenhuis IG, Mooij P, Verschoor EJ, Fagrouch ZC, Kondova I, Boonstra A, Koopman G. Role of microbial translocation in soluble CD14 up-regulation in HIV-, but not in HCV-, infected chimpanzees. J Gen Virol 2016;97:2599-607. [PMID: 27534537 DOI: 10.1099/jgv.0.000577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
28 Debes JD, Bohjanen PR, Boonstra A. Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection. J Clin Transl Hepatol. 2016;4:328-335. [PMID: 28097102 DOI: 10.14218/jcth.2016.00034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
29 Akil A, Endsley M, Shanmugam S, Saldarriaga O, Somasunderam A, Spratt H, Stevenson HL, Utay NS, Ferguson M, Yi M. Fibrogenic Gene Expression in Hepatic Stellate Cells Induced by HCV and HIV Replication in a Three Cell Co-Culture Model System. Sci Rep 2019;9:568. [PMID: 30679661 DOI: 10.1038/s41598-018-37071-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Abutaleb A, Sherman KE. A changing paradigm: management and treatment of the HCV/HIV-co-infected patient. Hepatol Int 2018;12:500-9. [PMID: 30238230 DOI: 10.1007/s12072-018-9896-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
31 Werbel WA, Durand CM. Solid Organ Transplantation in HIV-Infected Recipients: History, Progress, and Frontiers. Curr HIV/AIDS Rep 2019;16:191-203. [PMID: 31093920 DOI: 10.1007/s11904-019-00440-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
32 Carlisle LA, Turk T, Metzner KJ, Mbunkah HA, Shah C, Böni J, Huber M, Braun DL, Fehr J, Salazar-Vizcaya L, Rauch A, Yerly S, Nguyen A, Cavassini M, Stoeckle M, Vernazza P, Bernasconi E, Günthard HF, Kouyos RD. HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection. Viruses 2020;12:E1241. [PMID: 33142675 DOI: 10.3390/v12111241] [Reference Citation Analysis]
33 Restrepo C, Álvarez B, Valencia JL, García M, Navarrete-Muñoz MA, Ligos JM, Cabello A, Prieto L, Nistal S, Montoya M, Górgolas M, Rallón N, Benito JM. Both HCV Infection and Elevated Liver Stiffness Significantly Impacts on Several Parameters of T-Cells Homeostasis in HIV-Infected Patients. J Clin Med 2020;9:E2978. [PMID: 32942736 DOI: 10.3390/jcm9092978] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Hebeler-Barbosa F, Massolini VM, Watanabe T, Silva GF, Barbosa AN, Simões RP, Ferrasi AC, de Andrade Zanotto PM, de Moura Campos Pardini MI, Grotto RMT. Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients. Medicine (Baltimore) 2019;98:e16376. [PMID: 31335686 DOI: 10.1097/MD.0000000000016376] [Reference Citation Analysis]
35 Ahmed MH, Raza M, Lucas S, Mital D. Reactivation of the Epstein-Barr Virus Leading to Acute Liver Failure in a Patient Living with HIV. J Microsc Ultrastruct 2021;9:41-4. [PMID: 33850712 DOI: 10.4103/JMAU.JMAU_16_20] [Reference Citation Analysis]
36 Martinez SS, Campa A, Li Y, Fleetwood C, Stewart T, Ramamoorthy V, Baum MK. Low Plasma Zinc Is Associated with Higher Mitochondrial Oxidative Stress and Faster Liver Fibrosis Development in the Miami Adult Studies in HIV Cohort. J Nutr 2017;147:556-62. [PMID: 28228506 DOI: 10.3945/jn.116.243832] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
37 Johnson LP, Sterling RK. The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV-HCV Coinfection. Biology (Basel) 2020;9:E87. [PMID: 32344543 DOI: 10.3390/biology9040087] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Sagnelli C, Martini S, Pisaturo M, Pasquale G, Macera M, Zampino R, Coppola N, Sagnelli E. Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact. World J Hepatol 2015; 7(24): 2510-2521 [PMID: 26523204 DOI: 10.4254/wjh.v7.i24.2510] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
39 Patel SN, Delaney KP, Pitasi MA, Oraka E, Tao G, Van Handel M, Kilmer G, DiNenno EA. Self-Reported Prevalence of HIV Testing Among Those Reporting Having Been Diagnosed With Selected STIs or HCV, United States, 2005-2016. Sex Transm Dis 2020;47:S53-60. [PMID: 32332427 DOI: 10.1097/OLQ.0000000000001146] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Leite AG, Duarte MI, Mendes-Correa MC. Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C. J Int Assoc Provid AIDS Care 2015;14:463-8. [PMID: 26056147 DOI: 10.1177/2325957415587571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
41 Coronel-Castillo CE, Qi X, Contreras-Carmona J, Ramírez-Pérez OL, Méndez-Sánchez N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. Expert Rev Gastroenterol Hepatol 2019;13:531-40. [PMID: 30905208 DOI: 10.1080/17474124.2019.1599284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
42 Chen KY, Chiu CH, Wang LC. Anti-apoptotic effects of Sonic hedgehog signalling through oxidative stress reduction in astrocytes co-cultured with excretory-secretory products of larval Angiostrongylus cantonensis. Sci Rep 2017;7:41574. [PMID: 28169282 DOI: 10.1038/srep41574] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
43 Collazos J, Valle-Garay E, Suárez-Zarracina T, Montes AH, Cartón JA, Asensi V. Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients. World J Virol 2017; 6(2): 36-45 [PMID: 28573088 DOI: 10.5501/wjv.v6.i2.36] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
44 Pinato DJ, Allara E, Chen TY, Trevisani F, Minguez B, Zoli M, Harris M, Dalla Pria A, Merchante N, Platt H, Jain M, Caturelli E, Kikuchi L, Pineda J, Nelson M, Farinati F, Rapaccini GL, Aytaman A, Yin M, Tan CK, Bower M, Giannini EG, Bräu N; Liver Cancer in HIV and ITA.LI.CA Study Groups. Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. J Clin Oncol 2019;37:296-304. [PMID: 30562130 DOI: 10.1200/JCO.18.00885] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
45 Moore MS, Bocour A, Tran OC, Qiao B, Schymura MJ, Laraque F, Winters A. Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001-2012. Open Forum Infect Dis 2018;5:ofy144. [PMID: 30019001 DOI: 10.1093/ofid/ofy144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Latronico T, Mascia C, Pati I, Zuccala P, Mengoni F, Marocco R, Tieghi T, Belvisi V, Lichtner M, Vullo V, Mastroianni CM, Liuzzi GM. Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors. Int J Mol Sci. 2016;17:455. [PMID: 27023536 DOI: 10.3390/ijms17040455] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
47 Wu YJ, Xu MY, Lu LG. Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C. J Clin Transl Hepatol 2014;2:222-7. [PMID: 26357628 DOI: 10.14218/JCTH.2014.00029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]